검색
Sanara Medtech Inc
SMTI관심 목록에 추가
33.860USD
-0.200-0.59%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
311.28M시가총액
손실P/E TTM
자세한 내용은 Sanara Medtech Inc 회사
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Sanara Medtech Inc 정보
종목 코드 SMTI
회사 이름Sanara Medtech Inc
상장일Apr 07, 1994
CEOMuppalla (Suresh V)
직원 수141
유형Ordinary Share
회계 연도 종료Apr 07
주소1200 Summit Avenue
도시FORT WORTH
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호76102
전화18175292300
웹사이트https://sanaramedtech.com/
종목 코드 SMTI
상장일Apr 07, 1994
CEOMuppalla (Suresh V)
Sanara Medtech Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
자주 묻는 질문
Sanara Medtech Inc의 상위 5대 주주는 누구인가요?
Sanara Medtech Inc의 상위 5대 주주는 다음과 같습니다: Mr. Seth D. Yon
Sanara Medtech Inc(SMTI)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Sanara Medtech Inc의 주식을 보유한 기관은 총 131곳이며, 이들이 보유한 주식의 총 가치는 약 1.42M로 전체 발행 주식의 15.50%를 차지합니다. 이는 2025Q4 대비 -599767.00 증가한 수치입니다.
Sanara Medtech Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, Sanara Medtech Inc의 Soft tissue repair products 부문이 가장 높은 매출을 기록했으며, 금액은 91.35M로 전체 매출의 88.59%를 차지했습니다.